Xtant Net Receivables vs Other Current Liab Analysis

XTNT Stock

USD 0.40 0.01 2.44%

Xtant Medical financial indicator trend analysis is more than just analyzing Xtant Medical Holdings current accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Xtant Medical Holdings is a good investment. Please check the relationship between Xtant Medical Net Receivables and its Other Current Liab accounts. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Xtant Medical Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Net Receivables vs Other Current Liab

Net Receivables vs Other Current Liab Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Xtant Medical Holdings Net Receivables account and Other Current Liab. At this time, the significance of the direction appears to have fragmental relationship.

The correlation between Xtant Medical's Net Receivables and Other Current Liab is 0.42. Overlapping area represents the amount of variation of Net Receivables that can explain the historical movement of Other Current Liab in the same time period over historical financial statements of Xtant Medical Holdings, assuming nothing else is changed. The correlation between historical values of Xtant Medical's Net Receivables and Other Current Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Receivables of Xtant Medical Holdings are associated (or correlated) with its Other Current Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Current Liab has no effect on the direction of Net Receivables i.e., Xtant Medical's Net Receivables and Other Current Liab go up and down completely randomly.

Correlation Coefficient

0.42

Relationship Direction	Positive
Relationship Strength	Weak

View All Relationships

Net Receivables

Other Current Liab

Most indicators from Xtant Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Xtant Medical Holdings current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Xtant Medical Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

At this time, Xtant Medical's Sales General And Administrative To Revenue is comparatively stable compared to the past year. Enterprise Value Over EBITDA is likely to gain to 31.54 in 2024, whereas Issuance Of Capital Stock is likely to drop slightly above 9.6 M in 2024.

	2021	2022	2023	2024 (projected)
Gross Profit	32.5M	32.1M	55.5M	34.0M
Total Revenue	55.3M	58.0M	91.3M	53.7M

Gross Profit Total Revenue

Xtant Medical fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Cash	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Long Term Debt Total	Property Plant And Equipment Net	Current Deferred Revenue	Non Current Assets Total	Non Currrent Assets Other	Common Stock Total Equity	Non Current Liabilities Total	Property Plant And Equipment Gross	Short Term Debt	Intangible Assets
Total Assets		-0.08	0.83	0.0	0.76	-0.16	0.92	0.09	0.09	0.76	0.09	0.64	0.28	0.15	0.82	0.76	0.78	0.96	0.83	0.94	0.17	-0.24	0.75	0.48	0.15	0.91
Other Current Liab	-0.08		0.17	0.81	-0.54	-0.43	-0.14	0.16	0.16	0.42	0.79	0.56	0.36	0.64	-0.43	0.29	-0.54	-0.09	-0.1	-0.25	-0.33	-0.07	-0.58	0.62	0.35	-0.2
Total Current Liabilities	0.83	0.17		0.05	0.61	-0.34	0.77	-0.04	-0.04	0.7	0.16	0.71	0.46	0.32	0.65	0.72	0.61	0.83	0.79	0.73	-0.03	-0.25	0.53	0.45	0.55	0.66
Total Stockholder Equity	0.0	0.81	0.05		-0.62	-0.24	-0.17	0.37	0.37	0.31	0.76	0.41	0.16	0.53	-0.52	0.29	-0.6	-0.01	-0.22	-0.13	-0.18	-0.04	-0.64	0.51	0.39	-0.01
Net Debt	0.76	-0.54	0.61	-0.62		0.04	0.81	-0.27	-0.27	0.44	-0.4	0.28	0.05	-0.21	0.98	0.34	0.99	0.76	0.77	0.83	0.2	-0.19	0.99	0.13	-0.11	0.73
Retained Earnings	-0.16	-0.43	-0.34	-0.24	0.04		-0.05	-0.57	-0.57	-0.46	-0.72	-0.63	-0.68	-0.95	-0.05	-0.65	-0.02	-0.2	-0.35	0.13	0.62	0.65	0.05	-0.42	-0.39	0.18
Accounts Payable	0.92	-0.14	0.77	-0.17	0.81	-0.05		-0.07	-0.07	0.72	-0.03	0.59	0.19	0.02	0.87	0.64	0.82	0.89	0.77	0.88	0.26	-0.15	0.81	0.47	-0.03	0.82
Cash	0.09	0.16	-0.04	0.37	-0.27	-0.57	-0.07		1.0	0.09	0.55	0.15	0.42	0.6	-0.16	0.5	-0.16	0.04	0.11	-0.14	-0.25	-0.33	-0.17	0.01	0.05	-0.15
Cash And Short Term Investments	0.09	0.16	-0.04	0.37	-0.27	-0.57	-0.07	1.0		0.09	0.55	0.15	0.42	0.6	-0.16	0.5	-0.16	0.04	0.11	-0.14	-0.25	-0.33	-0.17	0.01	0.05	-0.15
Net Receivables	0.76	0.42	0.7	0.31	0.44	-0.46	0.72	0.09	0.09		0.55	0.94	0.31	0.53	0.56	0.77	0.45	0.79	0.61	0.61	-0.16	-0.3	0.41	0.89	0.18	0.6
Common Stock Shares Outstanding	0.09	0.79	0.16	0.76	-0.4	-0.72	-0.03	0.55	0.55	0.55		0.68	0.49	0.88	-0.26	0.56	-0.34	0.11	0.1	-0.16	-0.56	-0.44	-0.39	0.72	0.29	-0.14
Inventory	0.64	0.56	0.71	0.41	0.28	-0.63	0.59	0.15	0.15	0.94	0.68		0.48	0.71	0.41	0.78	0.3	0.67	0.59	0.45	-0.25	-0.39	0.24	0.9	0.32	0.43
Other Current Assets	0.28	0.36	0.46	0.16	0.05	-0.68	0.19	0.42	0.42	0.31	0.49	0.48		0.64	0.13	0.6	0.09	0.16	0.59	0.06	-0.27	-0.49	0.06	0.25	0.24	-0.04
Other Stockholder Equity	0.15	0.64	0.32	0.53	-0.21	-0.95	0.02	0.6	0.6	0.53	0.88	0.71	0.64		-0.1	0.66	-0.16	0.19	0.25	-0.14	-0.59	-0.58	-0.23	0.56	0.44	-0.15
Total Liab	0.82	-0.43	0.65	-0.52	0.98	-0.05	0.87	-0.16	-0.16	0.56	-0.26	0.41	0.13	-0.1		0.44	0.99	0.81	0.83	0.86	0.2	-0.22	0.98	0.25	-0.12	0.76
Total Current Assets	0.76	0.29	0.72	0.29	0.34	-0.65	0.64	0.5	0.5	0.77	0.56	0.78	0.6	0.66	0.44		0.4	0.75	0.67	0.49	-0.19	-0.4	0.35	0.58	0.29	0.46
Short Long Term Debt Total	0.78	-0.54	0.61	-0.6	0.99	-0.02	0.82	-0.16	-0.16	0.45	-0.34	0.3	0.09	-0.16	0.99	0.4		0.78	0.8	0.83	0.17	-0.24	0.99	0.12	-0.1	0.74
Property Plant And Equipment Net	0.96	-0.09	0.83	-0.01	0.76	-0.2	0.89	0.04	0.04	0.79	0.11	0.67	0.16	0.19	0.81	0.75	0.78		0.75	0.9	0.08	-0.25	0.73	0.53	0.25	0.87
Current Deferred Revenue	0.83	-0.1	0.79	-0.22	0.77	-0.35	0.77	0.11	0.11	0.61	0.1	0.59	0.59	0.25	0.83	0.67	0.8	0.75		0.76	-0.04	-0.35	0.76	0.34	0.11	0.62
Non Current Assets Total	0.94	-0.25	0.73	-0.13	0.83	0.13	0.88	-0.14	-0.14	0.61	-0.16	0.45	0.06	-0.14	0.86	0.49	0.83	0.9	0.76		0.32	-0.12	0.81	0.35	0.06	0.97
Non Currrent Assets Other	0.17	-0.33	-0.03	-0.18	0.2	0.62	0.26	-0.25	-0.25	-0.16	-0.56	-0.25	-0.27	-0.59	0.2	-0.19	0.17	0.08	-0.04	0.32		0.59	0.25	-0.25	-0.41	0.36
Common Stock Total Equity	-0.24	-0.07	-0.25	-0.04	-0.19	0.65	-0.15	-0.33	-0.33	-0.3	-0.44	-0.39	-0.49	-0.58	-0.22	-0.4	-0.24	-0.25	-0.35	-0.12	0.59		-0.17	-0.3	-0.3	-0.08
Non Current Liabilities Total	0.75	-0.58	0.53	-0.64	0.99	0.05	0.81	-0.17	-0.17	0.41	-0.39	0.24	0.06	-0.23	0.98	0.35	0.99	0.73	0.76	0.81	0.25	-0.17		0.09	-0.23	0.71
Property Plant And Equipment Gross	0.48	0.62	0.45	0.51	0.13	-0.42	0.47	0.01	0.01	0.89	0.72	0.9	0.25	0.56	0.25	0.58	0.12	0.53	0.34	0.35	-0.25	-0.3	0.09		0.14	0.37
Short Term Debt	0.15	0.35	0.55	0.39	-0.11	-0.39	-0.03	0.05	0.05	0.18	0.29	0.32	0.24	0.44	-0.12	0.29	-0.1	0.25	0.11	0.06	-0.41	-0.3	-0.23	0.14		0.08
Intangible Assets	0.91	-0.2	0.66	-0.01	0.73	0.18	0.82	-0.15	-0.15	0.6	-0.14	0.43	-0.04	-0.15	0.76	0.46	0.74	0.87	0.62	0.97	0.36	-0.08	0.71	0.37	0.08

Click cells to compare fundamentals

Xtant Medical Account Relationship Matchups

Xtant Medical fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	43.2M	41.5M	54.7M	60.2M	92.6M	60.0M
Other Current Liab	7K	5.7M	3.9M	5.0M	9.5M	10.0M
Total Current Liabilities	9.4M	25.6M	11.1M	15.2M	23.0M	16.0M
Total Stockholder Equity	(44.2M)	14.5M	30.9M	34.2M	51.3M	53.9M
Net Debt	73.3M	16.2M	(1.4M)	(3.2M)	17.8M	17.0M
Retained Earnings	(223.3M)	(230.3M)	(235.2M)	(243.7M)	(243.0M)	(230.9M)
Accounts Payable	2.2M	2.3M	2.6M	3.5M	7.1M	4.9M
Cash	5.2M	2.3M	18.2M	20.3M	5.7M	5.8M
Cash And Short Term Investments	5.2M	2.3M	18.2M	20.3M	5.7M	5.8M
Net Receivables	10.1M	6.9M	7.2M	10.9M	20.7M	21.8M
Common Stock Shares Outstanding	13.2M	28.5M	85.5M	94.1M	126.8M	133.1M
Liabilities And Stockholders Equity	43.2M	41.5M	54.7M	60.2M	92.6M	60.0M
Inventory	16.1M	21.4M	17.9M	17.3M	36.9M	38.7M
Other Current Assets	784K	1.5M	988K	1.6M	1.5M	830.2K
Other Stockholder Equity	179.1M	244.9M	266.1M	277.8M	294.3M	309.0M
Total Liab	87.4M	27.0M	23.8M	26.1M	41.3M	60.8M
Total Current Assets	32.2M	31.4M	44.3M	49.3M	64.9M	33.6M
Short Long Term Debt Total	78.5M	18.5M	16.8M	17.1M	23.6M	22.4M
Property Plant And Equipment Net	6.8M	6.0M	6.5M	7.2M	10.2M	7.8M
Non Current Assets Total	10.9M	10.1M	10.4M	10.9M	27.7M	28.2M
Non Currrent Assets Other	394K	402K	287K	197K	141K	134.0K
Non Current Liabilities Total	78.0M	1.3M	12.7M	10.8M	18.3M	17.4M
Property Plant And Equipment Gross	6.8M	4.3M	6.5M	7.2M	29.9M	31.4M
Short Term Debt	570K	17.7M	4.6M	6.8M	6.4M	3.9M
Intangible Assets	515K	457K	400K	344K	10.1M	7.8M
Other Assets	394K	2.1M	287K	197K	1.0	0.95
Long Term Debt	77.9M	76.2M	11.8M	9.7M	17.2M	16.3M
Property Plant Equipment	6.8M	4.3M	6.5M	5.8M	6.7M	7.6M
Retained Earnings Total Equity	(215.0M)	(223.3M)	(230.3M)	(243.7M)	(219.3M)	(208.3M)
Net Tangible Assets	(47.9M)	10.9M	27.3M	30.6M	35.2M	37.0M
Long Term Debt Total	138.6M	78.1M	76.2M	9.7M	8.7M	8.3M
Capital Surpluse	171.3M	179.1M	244.9M	277.8M	319.5M	177.0M
Capital Lease Obligations	2.3M	1.7M	1.4M	1.7M	1.8M	1.6M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Xtant Stock Analysis

When running Xtant Medical's price analysis, check to measure Xtant Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xtant Medical is operating at the current time. Most of Xtant Medical's value examination focuses on studying past and present price action to predict the probability of Xtant Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xtant Medical's price. Additionally, you may evaluate how the addition of Xtant Medical to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC